Oxygenation of human tumors-implications for combined therapy

Lung Cancer

Volumn 33, Issue SUPPL. 1, 2001, Pages

  Feldmann, Horst J ^a  

^a KLINIKUM FULDA   (Germany)

Author keywords

Erythropoietin; Hemoglobin level; Hypoxic cell sensitizer; Lung cancer; Modification of tumor oxygenation; Tumor oxygenation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTOSTATIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; OXYGEN; PACLITAXEL;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HEMOGLOBIN DETERMINATION; HUMAN; LUNG CANCER; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR OXYGENATION;

ANOXIA; COMBINED MODALITY THERAPY; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; OXYGEN;

EID: 0034823234     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00306-3     Document Type: Article

References (33)

1. Blood flow and oxygenation status of human tumors
2. The unique physiology of solid tumors: opportunities and problems for cancer therapy
3. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
4. Tumor hypoxia and heterogeneity: challenges and opportunities for the future
5. Hypoxic stress proteins: survival of the fittest
6. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors
7. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix
8. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
9. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
10. Influence of the hypoxic subvolume on the prognosis of head and neck cancer
11. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
12. Prognostic impact of the pretreatment pO2-histography in advanced head and neck cancer patients treated with primary radio- or radiochemotherapy
13. Significance of hemoglobin concentration for treatment outcome
14. The influence of anemia on the results of radiotherapy in carcinoma of the cervix
15. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone
16. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma
17. Survival determinants in extensive-stage non-small lung cancer
18. Prognostic factors for survival in inoperable non-small-cell lung cancer: a multivariate regression analysis of 456 patients with radiation therapy
19. Survival of exclusively irradiated patients with NSCLC. Significance of pretherapeutic hemoglobin level
20. The causes and prognostic significance of low hemoglobin levels in tumor patients
21. Chemotherapy-induced anemia in adults: incidence and treatment
22. Severe anemia ist associated with poor tumor oxygenation in head and neck squamous cell carcinomas
23. Blood flow, oxygenation and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats
24. Erythropoetin increases hemoglobin during radiation therapy for cervical cancer
25. Erythropoetin reduces anemia and transfusions: a randomized trial with or without erythropoietin during chemotherapy
26. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
27. Management of chemotherapy-induced anemia in solid tumors
28. Enhanced radiosensitivity in experimental tumors following erythropoietin treatment of chemotherapy-induced anemia
29. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture
30. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group
31. Oxygenation predicts radiation response and survival in patients with cervix cancer
32. The significance of anemia in clinical radiation therapy